Yifan Pharmaceutical Co., Ltd.
Industry Group: Pharmaceuticals
Country/Region: China
Identifier: SHE:002019
YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Pharmaceuticals 715 out of 923
Universe
Global Universe 13445 out of 16353
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Nippon Shinyaku Co., Ltd. |
29.2
Medium
|
481 out of 923 |
Tsumura & Co. |
31.3
High
|
592 out of 923 |
Hisamitsu Pharmaceutical Co., Inc. |
33
High
|
663 out of 923 |
Yifan Pharmaceutical Co., Ltd. |
34.1
High
|
715 out of 923 |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. |
38
High
|
859 out of 923 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Yifan Pharmaceutical Co., Ltd.'s Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Yifan Pharmaceutical Co., Ltd.'s Management of ESG Material Risk is Average